Cargando…

The Mcgill thyroid nodule score – does it help with indeterminate thyroid nodules?

BACKGROUND: Ultrasound guided fine-needle aspiration (USFNA) biopsy of thyroid nodules often gives a result of indeterminate pathology, placing thyroid specialists in difficult management situations. The aim of this study is to evaluate the incidence of malignancy in patients undergoing surgery and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varshney, Rickul, Forest, Veronique-Isabelle, Mascarella, Marco A, Zawawi, Faisal, Rochon, Louise, Hier, Michael P, Mlynarek, Alex, Tamilia, Michael, Payne, Richard J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323228/ https://www.ncbi.nlm.nih.gov/pubmed/25645364 http://dx.doi.org/10.1186/s40463-015-0058-6

Ejemplares similares

The McGill Thyroid Nodule Score’s (MTNS+) role in the investigation of thyroid nodules with benign ultrasound guided fine needle aspiration biopsies: a retrospective review
por: Khalife, Sarah, et al.
Publicado: (2016)

The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules
por: Jooya, Alborz, et al.
Publicado: (2016)

Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada
por: Rajab, Mohannad, et al.
Publicado: (2022)

Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
por: Turkdogan, Sena, et al.
Publicado: (2020)

Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review
por: Hier, Jessica, et al.
Publicado: (2021)

Intraoperative parathyroid hormone level in parathyroidectomy: which patients benefit from it?
por: Zawawi, Faisal, et al.
Publicado: (2013)

Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
por: Hosseini, S., et al.
Publicado: (2016)

Indeterminate Thyroid Nodules: When to Worry?
por: Tibbels, Amanda
Publicado: (2023)

Local molecular analysis of indeterminate thyroid nodules
por: Gill, Mandeep S., et al.
Publicado: (2015)

Coexisting Molecular Alterations Increase the Risk of Malignancy in Thyroid Nodules with Copy Number Alterations
por: Rajab, Mohannad, et al.
Publicado: (2022)

Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves’ disease patients: a retrospective matched cohort study
por: You, Eunice, et al.
Publicado: (2019)

Postthyroidectomy Throat Pain and Swallowing: Do Proton Pump Inhibitors Make a Difference?
por: Zawawi, Faisal, et al.
Publicado: (2013)

A Pragmatic Approach to the Indeterminate Thyroid Nodule
por: Seshadri, Krishna G.
Publicado: (2017)

Indeterminate thyroid nodules in the era of molecular genomics
por: Rao, Sarika N., et al.
Publicado: (2020)

Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB?
por: Ferraz, Carolina
Publicado: (2018)

Does the likelihood of malignancy in thyroid nodules with RAS mutations increase in direct proportion with the allele frequency percentage?
por: Hudson, Thomas J., et al.
Publicado: (2023)

Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
por: Jozaghi, Yelda, et al.
Publicado: (2013)

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
por: Turkdogan, Sena, et al.
Publicado: (2018)

Multiplatform molecular test performance in indeterminate thyroid nodules
por: Lupo, Mark A., et al.
Publicado: (2020)

Critical analysis of molecular tests in indeterminate thyroid nodules
por: Danilovic, Debora L. S., et al.
Publicado: (2018)

Indeterminate Thyroid Nodules: From Cytology to Molecular Testing
por: Vignali, Paola, et al.
Publicado: (2023)

The Difference in Clinical Behavior of Gene Fusions Involving RET/PTC Fusions and THADA/IGF2BP3 Fusions in Thyroid Nodules
por: Tali, George, et al.
Publicado: (2023)

ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology
por: Barbosa, Thayse Lozovoy Madsen, et al.
Publicado: (2019)

Q-Elastography in the Presurgical Diagnosis of Thyroid Nodules with Indeterminate Cytology
por: Cantisani, Vito, et al.
Publicado: (2012)

Indeterminate Thyroid Nodule: Mystery Continues Despite Recent Advances
por: Joshi, Ameya, et al.
Publicado: (2018)

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

Cost effectiveness of intraoperative pathology in the management of indeterminate thyroid nodules
por: Vuong, Christopher D., et al.
Publicado: (2020)

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
por: Polavarapu, Preethi, et al.
Publicado: (2021)

Thyroidectomy for Graves’ Disease Predicts Postoperative Neck Hematoma and Hypocalcemia: A North American cohort study
por: Mohtashami, Sadaf, et al.
Publicado: (2021)

Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations
por: Alohali, Sama, et al.
Publicado: (2023)

The role of repeat fine needle aspiration in managing indeterminate thyroid nodules
por: Allen, Laura, et al.
Publicado: (2019)

MON-LB75 Stratifying the Risk of Malignancy in Indeterminate Thyroid Nodules
por: Imam, Shahnawaz, et al.
Publicado: (2020)

Evaluation of LMR, NLR and PLR as predictors of malignancy in indeterminate thyroid nodules
por: Offi, Chiara, et al.
Publicado: (2021)

Clinical and ultrasonographic features in cancer risk stratification of indeterminate thyroid nodules
por: Alqahtani, Saad M., et al.
Publicado: (2022)

Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
por: Dharampal, Navjit, et al.
Publicado: (2022)

The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study
por: Sasson, Mark, et al.
Publicado: (2017)

BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
por: Pongsapich, Warut, et al.
Publicado: (2019)

A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology
por: Kloos, Richard T., et al.
Publicado: (2016)

Comparison of Thyroid Imaging Reporting and Data Systems in Malignancy Risk Stratification of Indeterminate Thyroid Nodules
por: Kim, Bo Hyun
Publicado: (2021)

Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
por: Whitmer, Dorota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dbertsml0mkth0cp8jct3hdfmg